Comparative Study of Kshara and Lavana formulation of Kantakari and their Clinical Efficacy in Bronchial Ashthma as Add-on Therapy

A Comparative Pharmaceutico – Analytical Study of Kshara and Lavana of Kantakari (Solanum virginianum L.) and to Evaluate their Clinical Efficacy as an Add-on Therapy in Bronchial Ashthma - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073678

Enrollment

Registered

2024-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Asthma since more than one year. 2. Patients on stable medication for one month. 3. Patient with partially or uncontrolled symptoms and/or FEV1 50-80% of predicted

Exclusion criteria

Exclusion criteria: 1. Age below 18 years and above 70 years. 2. Uncontrolled hypertension, diabetes or chronic systemic diseases 3. Cardiac diseases (IHD, CCF, DCM, RHD etc.) 4. Patient with respiratory infections in past one month. 5. Exacerbation in past one month 6. Patient with active tuberculosis, HIV etc 7. Patients with major systemic illness 8. Pregnant and lactating mothers 9. Any malignancy 10.Presence of other pulmonary disease like emphysema, cystic fibrosis etc.

Design outcomes

Primary

Measure	Time frame
Relief in Dyspnoea and CoughTimepoint: 15 days	—

Secondary

Measure	Time frame
Relief in all symptomsTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Jeel N Patel

Government Ayurved College and Hospital, Vadodara

dr.bhartiumrethia@gmail.com7600011944

Outcome results